HeLa (ATCC® CCL-2.1™) and THP-1 (ATCC® TIB-202™) cells were grown in RPMI1640 medium (Thermo Fisher Scientific, Dreieich, Germany) supplemented with 10% FCS (Sigma/Merck, Darmstadt, Germany). For differentiation of THP-1 cells into macrophages, 5 × 105 cells were seeded into a 12-well plate and treated with 20 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma/Merck, Darmstadt, Germany) for 72 h. HeLa cells with a knockout of Bax and Bak or overexpressing Bcl-XL were a kind gift from A. Weber and were generated as described before (Weber et al., 2016; Brokatzky et al., 2019). For S. negevensis preparation HeLa cells were grown to 50-60% confluence and infected in infection medium (RPMI w/o HEPES supplemented with 5% heat inactivated FCS) at MOI 1 for 6 h at 35°C, 5% CO2. Medium was then replaced by fresh infection medium and infected cells were grown for 3 days. Cells were mechanically detached, and bacteria released using ~ 2–5 mm glass beads (Carl Roth, Karlsruhe, Germany). Low speed supernatant (600 × g) was subjected to high-speed centrifugation (20,000 × g) to pellet bacteria. Bacteria were washed with 5 ml SPG buffer [250 mM sucrose, 4 mM monopotassium phosphate, 10 mM disodium phosphate, and 5 mM glutamate (pH 7.4)], aliquoted and stored at -80°C in the SPG buffer. Work with S. negevensis was conducted in a biosafety level 2 laboratory registered with the Government of Lower Franconia under code 55.1-8791.1.30.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.